ALEXANDRIA, Va., Oct. 6 -- United States Patent no. 12,751,918, issued on Oct. 6, was assigned to FRESENIUS KABI USA LLC (Lake Zurich, Ill.).
"Ketamine formulation" was invented by Jessica Rozemberg (Melrose Park, Ill.) and Jennifer Gehle-Novak (Melrose Park, Ill.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides a sterile, injectable pharmaceutical composition which includes a therapeutically effective amount of ketamine or a pharmaceutically acceptable salt thereof, a nitrite scavenger, a tonicity agent, and water, wherein the composition contains less than about 300 ppb of an N-nitrosoketamine impurity. The invention also provides a pharmaceutical product which includes a container and...